DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20195784

Cost comparison of commonly used antidepressant drugs with drug price control order in India

Narendra Kumar, Alisha Abbas, Akhlaque Ahmad, Reshma Choudhary, Arpan Ganguly, Rakesh Kumar Dixit

Abstract


Background: Price of a drug is an important factor for compliance to the treatment. So, to overcome the high prices of drugs, National Pharmaceutical Pricing Authority (NPPA) under government of India has issued Drug Price Control Order (DPCO) list containing commonly used drugs. Pharmaceutical companies can be punished if they keep their prices higher than the ceiling price mentioned in the DPCO. To find out the price variations of commonly used antidepressant drugs included in DPCO list of 29th April 2019.

Methods: A list of all oral antidepressant drugs included in DPCO of 29th April 2019 and available in Indian market was procured from medguide India. Analysis of number of total brands following as well as not following DPCO ceiling price was done.

Results: Author found 17 formulations of four antidepressant drugs included in DPCO. Total 556 brands found out of which 84.6% were following the DPCO and 15.4% of brands prices were higher than the ceiling price of DPCO.

Conclusions: Though large number of companies are following the DPCO but still strict regulation is needed to further increase the compliance of guidelines.


Keywords


Antidepressants, Drug price control order, Drug price, National pharmaceutical pricing authority

Full Text:

PDF

References


Atal S, Deshmankar B, Atal S, Nawaz SA. Cost analysis of commonly used drugs under price control in India: Assessing the effect of drug price control order on brand price variation. Int J Pharm Sci. 2016;8(4):315-21.

Shukla A, Sharma P. Cost variation study of antidepressant drugs. Inter J Basic Clini Pharmacol. 2016;5:1816-21.

Tripathi RK, Singh S. Cost variation analysis among different antidepressant drugs used to treat major depressive disorder. J Pharma Biol Sci. 2018;6(2):51-4.

DPCO/NPPA Department of Pharmaceuticals. Department of Pharmaceuticals, 2019. Available at: https://pharmaceuticals.gov.in/dpconppa. Accessed 4 October 2019.

Drug Price Control Orders (DPCO). Arthapedia, 2019. Available at: http://www.arthapedia.in/index. php?title=Drug_Price_Control_Orders_(DPCO). Accessed 5 October 2019.

Official Website of National Pharmaceutical Pricing Authority, Ministry of Chemicals and Fertilizers, Government of India, 2019. Available at: http://www.nppaindia.nic.in/. Accessed 5 October 2019.

Narula S. Current drug pricing status in India. Pharmacoeconomics. 2015;1(1):101.

Duffy L, Bacon F, Clarke CS, Donkor Y, Freemantle N, Gilbody S, et al. A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTi depressants to prevent reLapse in dEpRession): study protocol for a randomised controlled trial. Trials. 2019;20(1):319.

Santarsieri D, Schwartz TL. Antidepressant efficacy and side-effect burden: a quick guide for clinicians. Drugs Context. 2015;4:212-90.

Ghosh S, Roychaudhury S. Prescribing pattern of antidepressant drugs in a tertiary care hospital of eastern India. J Chem Pharma Res. 2014;6(6):2593-97.

Trivedi JK, Dhyani M, Sareen H, Yadav VS, Rai SB. Anti-depressant drug prescription pattern for depression at a tertiary health care center of Northern India. Med Pract Rev. 2010;1(2):16-8.

Kumar R, Kumar N, Ahmad A, Kumar M, Nath R, Dixit RK, et al. Cost comparison of antihypertensive drugs available in India with Drugs Prices Control Order price list. Inter J Res Med Sci. 2019;7(1):101-5.